Please login to the form below

Patient support blog series: Step 2 to a successful patient support programme

Break down those silos and work across internal and external stakeholders!


In my first blog post in this series ‘Step one:  Define your objectives and be able to measure and report on them’, we considered how to get clarity on the reasons why the organisation is investing in a PSP and on how you will measure success. Today we consider Step two.

Step two: Engage with stakeholders inside and outside of your organisation

Diseases don’t occur in a vacuum for those experiencing them, for those caring for patients, or for those trying to cure them. For any patient support programme to be successful, it needs to transcend the operational silos so prominent within the pharmaceutical industry – starting with internal stakeholders.

Internal stakeholders

Departments must work together, not just in sharing data, but in coordinating goals and objectives from the start.  Begin by mapping out all the internal stakeholders who will have a role in designing, delivering and using the outputs of the patient support programme.A multi-disciplinary workshop will allow you to understand what success looks like to each stakeholder. Certainly each department will expect different outcomes from the programme and will be able to use the data in different ways:

  • Market Access and HEOR teams will value real world data (e.g. disease outcomes, burden of disease and QoL) that can be used in peer-reviewed journals to support the value proposition and in negotiations with reimbursement authorities/formulary committees
  • Brand teams want successful launches, penetration and increased market share
  • Medical teams would like to see adherence and persistence data showing patients are staying on their medications as prescribed and clinical data showing the desired outcomes
  • Pharmacovigilance needs to monitor the performance of products in a wider population and look for uncommon side effects
Internal teams will be bought into the programme when they can see the benefits for patients and “what’s in it for them”. You will then need to work with these different departments as you design the programme, building in the steps to reach the desired outcomes.

Click here to read the full article, which goes on to consider how to engage with external stakeholders and understand their needs. 

Alternatively, contact Nagore.Fernandez@ashfieldhealthcare.com to find out how we can help you.  

17th August 2017

Share

Tags

Related content

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Add my company

Edit my company

Latest content on this profile

Double win for Pegasus at the Communique awards 2018
We are proud to announce the recent win at the Communiqué awards for Pegasus, an Ashfield company, part of UDG Healthcare, who scooped up two awards for their Small Talk Saves Lives campaign for Samaritans. The first award won was for Excellence in Public Health and the second win was for the category Excellence in Media Relations. Read more about the campaign here. In addition, at the end of the event Pegasus was also highly recommended for Best Consultancy of the Year!
Ashfield
Ashfield Digital & Creative wins IMA Best in Class Award
We are delighted to announce that Ashfield Digital & Creative, an Ashfield company, Part of UDG Healthcare plc, have been awarded an Interactive Media Awards (IMA) Best in Class 2018 for listentotheheart.co.uk in the ‘Medical Category’.
Ashfield
Ashfield Meetings & Events strengthens creative team following increase in requests to deliver global full service live events
Ashfield Meetings & Events (part of UDG Healthcare plc) has strengthened its UK creative team, as the largest event management agency specialising in the healthcare sector sees an increase in requests to deliver full service live events for global clients.
Ashfield
Download our infographic: Addressing the biggest challenges for rare disease communities
There have been huge advances in treatment options for rare diseases. Recently these have included advanced genetic therapies, such as viral mediated gene transfer and CAR-T therapies.
Ashfield
Pegasus opens health track at Cannes Lions
This year Ashfield Healthcare Communications integrated comms agency, Pegasus, was invited to open the health track.
Ashfield
Ashfield Meetings & Events welcomes largest intake of students in seventh year of undergraduate placement scheme
Ashfield Meetings & Events, the largest full service event management agency specialising in serving the healthcare sector, has this month welcomed its largest intake of students to its highly successful university placement scheme.
Ashfield